TABLE 4.

Detection of ETVr mutations by HBV DR v3 and direct sequencing at weeks 0, 24, 48, 72, 96, and 144

Case	INNO-LiPA detection		Direct-sequencing detection
	Wk	ETVr	Wk	ETVr
J20	96	ILFM184 + G202	96	L184 (L184 and G202 detected at wk 144)
J27	144	SCGA184 + T184	144	S184 + T184
J30	48	G202	96	G202 (NDb at wk 48)
J39	72	SCGA/ILFM184 + G202	96	I184, G202 (ND at wk 72)
J40	−8	G202	0	G202 (ND at wk −8)
J33	96	G202	144	G202 (ND at wk 96)
J19	24	G202 + C202	48	G202 (ND at wk 24)
J22	144	S202 + G202	144	S202
J28	0	SCGA184, V233	0	A184, V233
J37a	48	S202 + G202	48	S202
U42	80	SCGA184 + T184	80	T184 + A184
U72	144	T184 + SCGA184, S202 + G202	144	T184 + A184, S202
H55	48	T184 + ILFM184	48	T184

^aSwitched from ETV to LVD plus ADV therapy at week 60.

^bND, ETVr was not detected.